Cargando…

Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy

This study aims to investigate potential diabetic retinopathy (DR) risk factors by evaluating the circulating levels of pentosidine, soluble receptor for advanced glycation end-product (sRAGE), advanced oxidation protein product (AOPP) as well as glutathione peroxidase (GPx) and superoxide dismutase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Zhi Xiang, Chua, Kek Heng, Iqbal, Tajunisah, Kuppusamy, Umah Rani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645698/ https://www.ncbi.nlm.nih.gov/pubmed/23552832 http://dx.doi.org/10.3390/ijms14047480

Ejemplares similares

2245G/A polymorphism of the receptor for advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malaysian population
por: Ng, Zhi Xiang, et al.
Publicado: (2011)

Attenuated levels of pro-inflammatory markers in diabetic retinopathy patients undergoing treatment with antihyperglycemic and antihypertensive drugs
por: Ng, Zhi Xiang, et al.
Publicado: (2013)

Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease
por: Wong, Foo Nian, et al.
Publicado: (2016)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE
por: Wong, Foo Nian, et al.
Publicado: (2018)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
por: Kim, Taehee, et al.
Publicado: (2023)

The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
por: Erusalimsky, Jorge D.
Publicado: (2021)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021)

Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients
por: Jung, Eul Sik, et al.
Publicado: (2017)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
por: Chen, Der-Yuan, et al.
Publicado: (2015)

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018)

Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study
por: Saputra, Gusti Noor Ramadany, et al.
Publicado: (2022)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
por: Assiri, Adel M. A., et al.
Publicado: (2018)

Affimers as an Alternative to Antibodies in an Affinity LC–MS Assay for Quantification of the Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Human Serum
por: Klont, Frank, et al.
Publicado: (2018)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
por: Deo, Permal, et al.
Publicado: (2023)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss
por: Popp, Collin J, et al.
Publicado: (2022)

The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes
por: Klein, Ronald, et al.
Publicado: (2017)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality
por: Lim, Adeline, et al.
Publicado: (2021)

Concentrations of N(6)-Carboxymethyllysine (CML), N(6)-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
por: Damasiewicz-Bodzek, Aleksandra, et al.
Publicado: (2022)

The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients
por: Chiang, Kuang-Hsing, et al.
Publicado: (2018)

Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect
por: Haddad, Mohamed, et al.
Publicado: (2016)

Significant Interrelations among Serum Annexin A1, Soluble Receptor for Advanced Glycation End Products (sRAGE) and rs2070600 in Chronic Obstructive Pulmonary Disease
por: Kamel, Amira A., et al.
Publicado: (2022)

Protective effect of myricetin derivatives from Syzygium malaccense against hydrogen peroxide-induced stress in ARPE-19 cells
por: Arumugam, Bavani, et al.
Publicado: (2019)

Rosiglitazone enhances the apoptotic effect of 5-fluorouracil in colorectal cancer cells with high-glucose-induced glutathione
por: Lau, Meng-Fei, et al.
Publicado: (2019)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
por: Damasiewicz-Bodzek, Aleksandra, et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels
por: Aggarwal, Amita, et al.
Publicado: (2011)

Pleurotus giganteus (Berk. Karun & Hyde), the giant oyster mushroom inhibits NO production in LPS/H(2)O(2) stimulated RAW 264.7 cells via STAT 3 and COX-2 pathways
por: Baskaran, Asweni, et al.
Publicado: (2017)

Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells
por: Lau, Meng-Fei, et al.
Publicado: (2018)

Pentosidine, an Advanced Glycation End-Product, May Reflect Clinical and Morphological Features of Hand Osteoarthritis
por: Braun, Martin, et al.
Publicado: (2012)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Biswas, Subrata K.
Publicado: (2019)

Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid
por: Gryszczyńska, Bogna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9969d5pda98q51eimnv0fsubf9